How are CYP2D6 and menopause related?

The relationship between CYP2D6 and menopause is not well-established in scientific literature. CYP2D6 is an enzyme involved in metabolizing many drugs, including some used during menopause such as certain antidepressants (e.g., paroxetine) or tamoxifen for breast cancer risk. However, there is no strong evidence linking CYP2D6 genetic variants directly to menopause timing or symptom severity. Most data come from pharmacogenetic studies, not from menopause-specific research. A MyBody-X DNA test can report CYP2D6 variants, but its clinical utility for menopause is limited. The evidence is primarily marketing-based and lacks robust human studies. Caveat: do not change medication based on such a test; always consult a healthcare professional.